The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...

The Food and Drug Administration on Wednesday approved Eli Lilly’s diabetes drug for treating obesity, opening the door for ...

The FDA recently approved Zepbound, a weekly injectable drug targeted to treat obesity. The medication contains tirzepatide, the same active ingredient that is also present in the diabetes drug ...

A controversial anti-obesity drug is set to become more widely available on the NHS. Orlistat, otherwise known as Xenical, has been prescribed free to some obese patients for the past two years.

The FDA has approved PureTech Health’s ‘space ... the pharmaceutical company whose products have emerged as the biggest selling anti-obesity drugs. In contrast, PureTech said Plenity is ...

the latest and most potent injectable anti-obesity medication approved by the FDA, may be an effective treatment for certain ...

In this article, we provide an overview of currently available anti-obesity agents ... interventions to treat obesity. Despite these high demands for new drug approval, the market for a safe ...

The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...

The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Sanders, but Novo CEO blames PBMs for high Wegovy prices About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be about $10,000 ...

More severe side effects can include pancreatitis, vision changes, allergic reactions, fatigue or dizziness, gallstones, ...